Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,287 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Physiological Assessment with iFR prior to FFR Measurement in Left Main Disease.
Warisawa T, Cook CM, Ahmad Y, Howard JP, Seligman H, Rajkumar C, Toya T, Doi S, Nakajima A, Nakayama M, Vera-Urquiza R, Yuasa S, Sato T, Kikuta Y, Kawase Y, Nishina H, Al-Lamee R, Sen S, Lerman A, Matsuo H, Akashi YJ, Escaned J, Davies JE. Warisawa T, et al. Among authors: nakayama m. Cardiovasc Interv Ther. 2024 Jul;39(3):241-251. doi: 10.1007/s12928-024-00989-4. Epub 2024 Apr 20. Cardiovasc Interv Ther. 2024. PMID: 38642290 Free PMC article.
Impact of hyperaemic stenosis resistance on long-term outcomes of stable angina in the ILIAS Registry.
Boerhout CKM, Echavarría-Pinto M, de Waard GA, Lee JM, Mejía-Rentería H, Hun Lee S, Jung JH, Hoshino M, Matsuo H, Madera-Cambero M, Eftekhari A, Effat MA, Murai T, Marques K, Doh JH, Christiansen EH, Banerjee R, Nam CW, Niccoli G, Nakayama M, Tanaka N, Shin ES, Beijk MAM, van Royen N, Knaapen P, Escaned J, Kakuta T, Koo BK, Piek JJ, van de Hoef TP, Meuwissen M. Boerhout CKM, et al. Among authors: nakayama m. EuroIntervention. 2024 Jun 3;20(11):e699-e706. doi: 10.4244/EIJ-D-23-00713. EuroIntervention. 2024. PMID: 38840578 Free article.
Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.
Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N, Jinnouchi H, Sugiyama S, Saito Y; Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators. Ogawa H, et al. Among authors: nakayama m. JAMA. 2008 Nov 12;300(18):2134-41. doi: 10.1001/jama.2008.623. Epub 2008 Nov 9. JAMA. 2008. PMID: 18997198 Clinical Trial.
Achievement of guideline-recommended target blood pressure is associated with reducing the risk of hemorrhagic and ischemic stroke in Japanese coronary artery disease patients -the CLIDAS study.
Oba Y, Kabutoya T, Kohro T, Imai Y, Kario K, Sato H, Nochioka K, Nakayama M, Akashi N, Fujita H, Mizuno Y, Kiyosue A, Iwai T, Miyamoto Y, Nakano Y, Ishii M, Nakamura T, Tsujita K, Matoba T, Nagai R; CLIDAS research group. Oba Y, et al. Among authors: nakayama m. Hypertens Res. 2024 Sep 19. doi: 10.1038/s41440-024-01902-5. Online ahead of print. Hypertens Res. 2024. PMID: 39300294
Corrigendum to "Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events" [Int. J. Cardiol. Cardiovasc. Risk and Prev. 2023 Jun 25:18:200193].
Ikebe S, Ishii M, Otsuka Y, Nakamura T, Tsujita K, Matoba T, Kohro T, Oba Y, Kabutoya T, Imai Y, Kario K, Kiyosue A, Mizuno Y, Nochioka K, Nakayama M, Iwai T, Miyamoto Y, Sato H, Akashi N, Fujita H, Nagai R; of the CLIDAS research group. Ikebe S, et al. Among authors: nakayama m. Int J Cardiol Cardiovasc Risk Prev. 2024 Jul 5;22:200304. doi: 10.1016/j.ijcrp.2024.200304. eCollection 2024 Sep. Int J Cardiol Cardiovasc Risk Prev. 2024. PMID: 39280775 Free PMC article.
Change in pulse pressure and cardiovascular outcomes after percutaneous coronary intervention: The CLIDAS study.
Nochioka K, Nakayama M, Akashi N, Matoba T, Kohro T, Oba Y, Kabutoya T, Imai Y, Kario K, Kiyosue A, Mizuno Y, Iwai T, Miyamoto Y, Ishii M, Nakamura T, Tsujita K, Sato H, Fujita H, Nagai R; CLIDAS research group. Nochioka K, et al. Among authors: nakayama m. Int J Cardiol Heart Vasc. 2024 May 24;53:101430. doi: 10.1016/j.ijcha.2024.101430. eCollection 2024 Aug. Int J Cardiol Heart Vasc. 2024. PMID: 39228973 Free PMC article.
Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan.
Yoshimura A, Kato T, Nakai Y, Tsujihata M, Toyoda S, Sato M, Matsuzaki K, Nakata W, Takao T, Inoguchi S, Okuda Y, Yamamichi G, Ishizuya Y, Yamamoto Y, Hatano K, Kawashima A, Takada S, Inoue H, Nishimura K, Miyake O, Fujita K, Nakayama M, Nishimura K, Nonomura N. Yoshimura A, et al. Among authors: nakayama m. Int J Clin Oncol. 2024 Sep 2. doi: 10.1007/s10147-024-02612-1. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39222148
3,287 results